Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy

It is unclear whether asthma and asthma medications increase or decrease the risk of severe COVID-19, and this is particularly true for patients with severe asthma receiving biologics.

Source: Respiratory Medicine - December 22, 2020 Category: Respiratory Medicine Authors: Katrien Eger, Simone Hashimoto, Gert Jan Braunstahl, Anneke ten Brinke, Kornelis W. Patberg, Annelies Beukert, Frank Smeenk, Simone van der Sar –van der Brugge, Els J.M. Weersink, Elisabeth H. Bel Source Type: research